TRCT
IMCR icon

Tower Research Capital (TRC)’s Immunocore IMCR Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Sell
438
-1,435
-77% -$46.4K ﹤0.01% 3755
2025
Q4 		$65K Buy
1,873
+1,502
+405% +$53K ﹤0.01% 2236
2025
Q3 		$13.5K Buy
+371
New +$12.6K ﹤0.01% 3675
2025
Q2 		– Sell
-2,086
Closed -$61.9K – 5410
2025
Q1 		$61.9K Buy
2,086
+1,400
+204% +$42K ﹤0.01% 2077
2024
Q4 		$20.2K Sell
686
-276
-29% -$8.73K ﹤0.01% 3174
2024
Q3 		$29.9K Sell
962
-20,588
-96% -$749K ﹤0.01% 3008
2024
Q2 		$730K Buy
21,550
+20,515
+1,982% +$1.05M 0.01% 1015
2024
Q1 		$67.3K Buy
1,035
+724
+233% +$49.7K ﹤0.01% 2083
2023
Q4 		$21.2K Sell
311
-3,077
-91% -$160K ﹤0.01% 3609
2023
Q3 		$176K Buy
3,388
+820
+32% +$48.5K 0.01% 1522
2023
Q2 		$154K Sell
2,568
-3,820
-60% -$218K 0.01% 1734
2023
Q1 		$316K Buy
6,388
+4,147
+185% +$233K 0.01% 1111
2022
Q4 		$128K Sell
2,241
-904
-29% -$50.9K 0.01% 1635
2022
Q3 		$148K Buy
3,145
+2,860
+1,004% +$136K ﹤0.01% 2206
2022
Q2 		$11K Buy
+285
New +$9.26K ﹤0.01% 4375
2022
Q1 		– Sell
-19
Closed -$1K – 6302
2021
Q4 		$1K Buy
+19
New +$688 ﹤0.01% 5835

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Tower Research Capital (TRC)'s IMCR Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Immunocore (IMCR) stake by 77% in Q1 2026, selling an estimated $46.4K and leaving 438 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3755.

Tower Research Capital (TRC) first reported a position in IMCR in Q4 2021 and has held it in 16 quarters since. The position peaked at $730K in Q2 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Tower Research Capital (TRC) held 438 shares of Immunocore worth $13.2K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,435 Immunocore shares in Q1 2026, an estimated $46.4K.
  • Immunocore made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3755 holding.
  • Tower Research Capital (TRC) first reported a position in Immunocore in Q4 2021 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s Immunocore position peaked at $730K in Q2 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.